Diabetes Care: A global epidemiological analysis of end-stage kidney disease associated with diabetes

Worldwide, the annual risk of diabetics reaching end-stage kidney disease (ESRD) is largely unknown.
a recent study published in Diabetes Care, an authoritative journal in the field of diabetes, aims to compare the incidence of diabetes-related ESRD by creating a global atlas from 2000 to 2015.
incidence of ESRD in patients with diabetes was calculated by divided by the number of people with diabetes ESRD divided by the number of patients with ESRD in the past.
ESRD prevalence and annual morbidity were validated using data from the Fresenius health care system in Germany and previously reported data, respectively.
the study came from 142 countries, accounting for 97.3 per cent of the world's population.
the global incidence of ESRD among diabetics worldwide increased from 19.0% in 2000 to 29.7% in 2015, while the proportion of diabetes-caused ESRD events increased from 22.1% to 31.3%.
between 2000 and 2015, the incidence of ESRD among people with diabetes worldwide rose from 375.8 to 1016.0 per million.
the highest average incidence was observed in the Western Pacific.
, between 2000 and 2015, the incidence of ESRD among people with diabetes in Europe was between half (309.2 vs. 544.6) and one-third (419.4 vs. 1245.2).
result, there are significant and non-random geographic differences in the annual incidence of diabetes developing into ESRD, with unique health care, environmental and/or genetic factors promoting the progression of diabetic nephropathy.
measures to prevent and treat diabetes-related ESRD require susceptible stratization of patients.